Chart of the Week: 3x Improvement in Likelihood of Approval

Sep 12, 2016 | News

In May we released a report co-authored with BIO and BioMedTracker. One of the key take-aways from the report is that patient selection biomarkers, if used successfully, can triple the Likelihood of Approval (LOA) for clinical studies.  Here is the data: Share this...

Chart of the Week: Cost of Biomarker Information

Aug 26, 2016 | Biomarkers, News

It is more costly to get biomarker information from public sources than you think. The volume of information requires technology assistance to be efficient. AI approaches like Natural Language Processing (NLP) are the best bet for efficient gathering of clinical...

Chart of the Week: Biopharma Players in Alzheimers

Jun 8, 2016 | News

We’ve published a few “graphs” illustrating topics interesting to us.  Last month published a graph showing Celgene’s biomarker and trial activities.  More recently we published a biomarker and trial landscape graph for Alzheimer’s...

Are Things Getting Any Better in the Clinic?

Jun 2, 2016 | News

This blog was originally published on the Science Translational Medicine Blog, In The Pipeline by Derek Low on June 2, 2016. Here’s an updated look at clinical success rates in the biotech industry, from the BIO industry organization. They’re looking at only...

Cancer Drugs: A Long Road to Blockbuster Sales

May 30, 2016 | News

This article was originally published on WSJ.com by Charley Grant on May 30, 2016. Novel cancer treatments are the next big hope for the drug sector. But investors shouldn’t forget that reward goes hand in hand with risk. Download the full report: Clincial Development...